Answers are grounded in this paper and cite their sources.
Male infertility is a common and complex disease. As with most common diseases, male infertility is characterized by heterogeneity of phenotypes and probably includes genetic heterogeneity (different genetic polymorphisms causing similar phenotypes) and environmental components (Carrell, 2007). Furthermore, the difficult quest to unlock the causes of male infertility is compounded by the unique nature of spermatogenesis, including the quantity of genes/proteins involved (likely more than 2000 genes), the process of meiotic recombination and reduction, complex endocrine and paracrine regulatory networks and the highly specialized morphogenesis of a mature spermatozoon (McLachlan et al., 1998). Spermiogenesis, the morphogenesis of a round spermatid into a spermatozoon, introduces further complexity by the temporal uncoupling of transcription and translation of many proteins because of quiescence of transcription during the compaction of chromatin (Iguchi et al., 2006). Hence, the current lack of identification of gene mutations that are responsible for a high percentage of male infertility is not surprising and portends the need to study novel genetic and epigenetic processes involved in spermatogenesis (Nuti & Krausz, 2008). One interesting facet of male infertility is the coexistence of diverse pathologies observed in many patients. For example, a patient may simultaneously exhibit oligozoospermia and sperm chromosome aneuploidy that are seemingly effects of aberrant meiosis, while simultaneously having teratozoospermia or diminished sperm penetration ability, defects that are probably the results of abnormal spermiogenesis. For example, infertile men with abnormal protamine replacement of histones during chromatin compaction often also exhibit diminished sperm concentrations and decreased fertilization ability, both seemingly unrelated to chromatin modification (Carrell & Liu, 2001). The link between these diverse pathologies may reside in aberrant function of the regulatory processes for of transcription of gene families by transcription factors or epigenetic factors, and/or abnormal regulation of translation of the transcripts by common translation regulators (Carrell et al., 2007). Two presentations at the recent Florence/Utah Symposium on the Genetics of Male Infertility highlighted potential transcription and/or translation regulators and are presented in this issue (Xu & Hecht, 2008; Shanker et al., 2008). First, Xu and Hecht review recent work that demonstrates the key role of MSY2, a DNA and mRNA binding protein, in stabilizing a wide family of spermiognesis mRNAs, thereby regulating their translation. Understanding the mechanism for regulating translation of a large and diverse family of transcripts may be directly applicable to understanding male infertility, as is highlighted by the recent report of polymorphisms of the YBX2 gene, the human homologue of MSY2, in infertile men (Hammoud et al., 2008). Xu and Hecht also review recent work from their laboratory on a second translation regulator, polypyrimidine tract binding protein 2 (PTBP2) that splices mRNAs and stores them in the cytoplasm. Understanding the regulation of transcription includes both genetic and epigenetic pathways (Hogeveen & Sassone-Corsi, 2006; Khalil & Wahlstedt, 2008; Sands & Palmer, 2008). An example of this is the review of recent work by Shanker et al. elucidating the role of the Rhox5 gene in spermatogenesis. Rhox5 is a member of the Rhox family of homeobox genes located on the X chromosome. Rhox5 is expressed in the testis and regulated in part not only by androgens, but also by epigenetic modification. Rhox5 appears to be an important transcriptional regulator and Shanker et al. review the possible downstream targets of Rhox5 expression. These studies demonstrate a complex regulatory pathway and identify a potentially clinically relevant transcription regulator. The two Florence/Utah symposium papers highlighted in this issue demonstrate examples of how transcription and translation regulatory networks affect a broad range of downstream targets. Defects in regulators such as these may be responsible for the paradoxical presentation of seemingly unrelated pathologies. It is likely that these studies and future efforts in identifying and clarifying the role of such regulatory networks will be important in understanding the common causes of male infertility.
No takes yet. Share an insight, caveat, or question.
Douglas T. Carrell (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: